Zimmer Biomet Holdings Americas — Revenue decreased by 6.3% to $1.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $1.21B to $1.32B. Over 4 years (FY 2021 to FY 2025), Americas — Revenue shows an upward trend with a 5.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher revenue indicates strong market demand and effective sales execution in the Americas.
Total revenue generated from the sale of products and services within the Americas segment, excluding sales taxes or oth...
The standard benchmark for segment-level revenue growth across all industries.
zbh_segment_americas_revenue_from_contract_with_customer_excluding_assessed_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.06B | $1.01B | $1.09B | $1.00B | $1.09B | $1.05B | $1.15B | $1.14B | $1.16B | $1.11B | $1.21B | $1.19B | $1.20B | $1.14B | $1.27B | $1.21B | $1.27B | $1.25B | $1.41B | $1.32B |
| QoQ Change | — | -4.6% | +7.8% | -7.7% | +8.8% | -4.4% | +10.4% | -1.0% | +1.3% | -3.7% | +8.9% | -2.2% | +1.1% | -5.3% | +12.1% | -5.2% | +5.5% | -1.6% | +12.7% | -6.3% |
| YoY Change | — | — | — | — | +3.3% | +3.5% | +6.0% | +13.6% | +5.8% | +6.6% | +5.2% | +4.0% | +3.7% | +2.0% | +4.9% | +1.7% | +6.2% | +10.4% | +11.0% | +9.7% |